The abstract is read at the publisher; the summary is JClub's.
Loss of Dusp5 in tumor-reactive CD8+ T cells improves tumor control in both young and aged mice by broadly restraining ERK-dependent proliferation.
- Why it matters: The aged tumor microenvironment can blunt antitumor T cell function, but the specific genetic regulators that become limiting with age are not well defined.
- What they did: Chen and colleagues used in vivo CRISPR screening to compare genetic perturbations in tumor-reactive CD8+ T cells across young versus aged hosts, then validated Dusp5 and Zfp219 roles.
- The result: Zfp219 deletion preferentially boosts cytotoxicity and tumor control in aged mice, enhances PD-1 blockade responses with complete clearance in a subset, and links higher ZNF219 in intratumoral CD8+ T cells to worse human outcomes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.